Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
Emory fires Iranian official’s daughter after campus protests...
World Health Organization says US withdrawal makes the...
Trump’s NATO warning pushes Europe to face the...
Battleground GOP lawmaker moves to block what he...
GOP senators launch task force to crack down...
Venezuelan opposition leader says democratic transition would be...
Iran regime reportedly issued nationwide shoot-to-kill orders as...
Pentagon warns future wars may hit US soil...
Lahontan Mobilizes Core Drill Rig to Santa Fe
Copper Quest Announces $1,950,000 Investment by Strategic International...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Politics

Former Biden doctor asks to delay testimony to House committee investigating mental fitness

by admin July 8, 2025
July 8, 2025
Former Biden doctor asks to delay testimony to House committee investigating mental fitness

Former White House physician Kevin O’Connor, who served as doctor to former President Joe Biden, requested a delay to his upcoming testimony before the House Oversight Committee this week.

O’Connor was scheduled to testify on Wednesday, but is now in a disagreement with the committee over the scope of the questions he will be expected to answer during his testimony. The committee, led by Chairman James Comer, R-Ky., is interviewing the doctor as part of its investigation into Biden’s mental fitness and his administration’s use of an autopen.

A lawyer for O’Connor requested the testimony be delayed to July 28 or August 4 in a letter to Comer.

‘Dr. O’Connor has legal and ethical obligations that he must satisfy and for which violations carry serious consequences to him professionally and personally,’ the letter says.

‘We are unaware of any prior occasion on which a Congressional Committee has subpoenaed a physician to testify about the treatment of an individual patient.  And the notion that a Congressional Committee would do so without any regard whatsoever for the confidentiality of the physician-patient relationship is alarming.’

A spokesman for the Oversight Committee replied in a statement that O’Connor and his legal team were merely trying to ‘stonewall’ the process. The committee is planning to move forward with Wednesday’s testimony, which O’Connor faces a subpoena to attend.

The committee said O’Connor is welcome to object to individual questions during his testimony. But O’Connor is not allowed, in the committee’s view, to delay or decline a congressional subpoena due to concerns over questions about potentially privileged information.

The debate over O’Connor’s testimony comes weeks after a former top aide to Biden, Neera Tanden, told the Oversight Committee that she was authorized to direct autopen signatures but was unaware of who in the president’s inner circle was giving her final clearance.

During Tanden’s interview before Congress last month, which lasted more than five hours, she told lawmakers that, in her role as staff secretary and senior advisor to the former president between 2021 and 2023, she was authorized to direct autopen signatures on behalf of Biden, an Oversight Committee official told Fox News.

‘Ms. Tanden testified that she had minimal interaction with President Biden, despite wielding tremendous authority,’ Comer said at the time. ‘She explained that to obtain approval for autopen signatures, she would send decision memos to members of the President’s inner circle and had no visibility of what occurred between sending the memo and receiving it back with approval. Her testimony raises serious questions about who was really calling the shots in the Biden White House amid the President’s obvious decline. We will continue to pursue the truth for the American people.’

Fox News’ Kelly Phares and Madeleine Rivera and the Associated Press contributed to this report.

This post appeared first on FOX NEWS

previous post
New book exposes Jill Biden’s power grab amid husband’s political demise
next post
Key advisor called Hunter Biden’s role on strategy call ‘inappropriate’ after he overruled legal guidance

You may also like

Senate GOP ready to go nuclear after Schumer’s...

August 6, 2025

House Oversight Committee releases thousands of Epstein documents

September 3, 2025

How Kamala Harris’ failed 2024 presidential run mirrors...

November 7, 2024

Harris-Trump showdown: Margin-of-error presidential race with one week...

October 29, 2024

Biden is in charge of country on second...

August 27, 2024

Putin signs revised doctrine lowering threshold for nuclear...

November 19, 2024

MTG defends herself as ‘America first’ after Trump...

December 8, 2025

Biden pardons late Black activist Marcus Garvey, 4...

January 19, 2025

Ukraine’s Zelenskyy replaces top military official ahead of...

March 18, 2025

SEN LINDSEY GRAHAM: Comey’s FBI investigated me and...

October 22, 2025

Recent Posts

  • Emory fires Iranian official’s daughter after campus protests over controversial hiring decision
  • World Health Organization says US withdrawal makes the nation and the world ‘less safe’
  • Trump’s NATO warning pushes Europe to face the cost of defending itself
  • Battleground GOP lawmaker moves to block what he calls Democratic redistricting ‘power grab’
  • GOP senators launch task force to crack down on fraud tied to Minnesota scandal

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (967)
    • Investing (3,957)
    • Politics (4,780)
    • Stock (4)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 Sightful Invest. All Rights Reserved.